Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
